| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/17/2006 | US20060182726 Immunomodulating compositions, processes for their production and uses therefor |
| 08/17/2006 | US20060182719 administering a nucleic acid encoding Ebp1 protein for suppressing or slowing the growth of prostate cancer; delivery a lentiviral vector biodrug as anticarcinogenic agent |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182717 Vector for expressing alpha-N-acetyl-galactosaminidase and method of treating MPS I by stereotactic injection into the brain of a mammal |
| 08/17/2006 | US20060182713 Vaccine composition comprising interleukin-15 (il-15) |
| 08/17/2006 | US20060182683 Methods for reduced renal uptake of protein conjugates |
| 08/17/2006 | CA2600765A1 Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by insulin-like growth factor binding protein-3 (igfbp-3) |
| 08/17/2006 | CA2599036A1 Replication-deficient rna viruses as vaccines |
| 08/17/2006 | CA2597335A1 Neuroprotective agents and methods of their use |
| 08/17/2006 | CA2595495A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | CA2572921A1 Venezuelan equine encephalitis (vee) viral adjuvants |
| 08/16/2006 | EP1690937A1 Method of constructing transgenic dendritic cell |
| 08/16/2006 | EP1690936A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene |
| 08/16/2006 | EP1690546A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 08/16/2006 | EP1690544A2 Pharmaceutical composition containing decoy and method of using the same |
| 08/16/2006 | EP1689872A1 Promoters for expression in modified vaccinia virus ankara |
| 08/16/2006 | EP1689866A2 Msp-3-like family of genes |
| 08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |
| 08/16/2006 | EP1689446A2 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses |
| 08/16/2006 | EP1689445A1 Novel use of adenoviruses and nucleic acids that code for said viruses |
| 08/16/2006 | EP1689444A1 Dna delivery with gemini cationic surfactants |
| 08/16/2006 | EP1689436A1 TREATMENT OF RHEUMATOID ARTHRITIS WITH HYPOXIA-INDUCIBLE FACTOR a ANTAGONISTS |
| 08/16/2006 | EP1689428A2 Minimization of drug oxidation in drug irradiated excipients formulations |
| 08/16/2006 | EP1689230A2 Compositions and methods for systemic nucleic acid sequence delivery |
| 08/16/2006 | EP1601772A4 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1296647B1 Polymeric micelle compositions |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1268530B1 Hepatitis b core antigen fusion proteins |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP0972037B1 Beta-catenin, tcf-4, and apc interact to prevent cancer |
| 08/16/2006 | EP0836484B1 In vitro packaging of adeno-associated virus dna |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | CN1820200A Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820020A SARS-coronavirus virus-like particles and methods of use |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819841A Methods of enhancing immune induction involving mda-7 |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1269963C Cardiac atrium peptide gene transfecting cell microcapsule |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269958C Zinc finger binding domains for GNN |
| 08/16/2006 | CN1269524C Thymosin augmentation of genetic immunization |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091332 For expressing in mammalian cells microbial proteins that have anti-microbial, particularly anti-staphylococcal, activity; for therapy of mastitis in ruminant animals |
| 08/15/2006 | US7091041 Micellar systems |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091038 Ecdysone receptor-based inducible gene expression system |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7091028 Method for directed packaging of molecular substances in protein shells |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/15/2006 | US7090837 comprises attachment incompetent fusogenic polypeptide (lentivirus or influenza hemagglutinin) and heterologous targeting polypeptide (chimeric, with transmembrane cd40 domain); gag genes/proteins; pol genes/proteins; rev genes/proteins; gene therapy |
| 08/15/2006 | US7090836 Vector for expressing α-L-iduronidase and method of treating MPS I by stereotactic injection into the brain of a mammal |
| 08/15/2006 | CA2266622C Hyaluronic drug delivery system |
| 08/15/2006 | CA2258554C Method for providing dense particle compositions for use in transdermal particle delivery |
| 08/10/2006 | WO2006084243A2 Compositions and methods for the therapeutic treatment of diabetes |
| 08/10/2006 | WO2006084233A2 Modulation of endogenous aicar levels for the treatment of diabetes and obesity |
| 08/10/2006 | WO2006084191A2 Local gene therapy with an eluting stent for vascular injury |
| 08/10/2006 | WO2006083798A2 Methods for treating obesity-related disorders by inhibiting myd88 and methods for identifying myd88 inhibitors |
| 08/10/2006 | WO2006083797A2 Improving and protecting cell therapy for neurological disorders including parkinson's disease |
| 08/10/2006 | WO2006083373A2 Methods and compositions for modulating keratinocyte function |
| 08/10/2006 | WO2006083355A2 Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics |
| 08/10/2006 | WO2006083183A1 Use of myostatin (gdf-8) antagonists for treatment of sarcopenia (age-related muscle-wasting) |
| 08/10/2006 | WO2006083182A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease |
| 08/10/2006 | WO2006083051A1 G6pd enzyme inhibitor and method for treating obesity using the same |
| 08/10/2006 | WO2006082088A1 Ester-linked gemini surfactant compounds for use in gene therapy |
| 08/10/2006 | WO2006081629A1 Adenoviral vectors comprising a nucleic acid encoding a mhc class i molecule and the use of such vectors in cancer therapy. |
| 08/10/2006 | WO2006066066A3 Chimeric vectors |
| 08/10/2006 | WO2006059081A3 Methods of treatment using melanopsin |
| 08/10/2006 | WO2006047301A9 Parvovirus methods and compositions for killing neoplastic cells |
| 08/10/2006 | WO2006033689A3 Aav mediated gene delivery to cochlear cells |
| 08/10/2006 | WO2005115481A3 Nuclease resistant double-stranded ribonucleic acid |
| 08/10/2006 | WO2005110493A3 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress |
| 08/10/2006 | WO2005103716A3 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 08/10/2006 | WO2005086804A3 Modulation of ace2 expression |
| 08/10/2006 | WO2005027962A9 4’-thionucleosides and oligomeric compounds |
| 08/10/2006 | WO2005017101A3 Avian adenoassociated virus (aaav) and uses thereof |
| 08/10/2006 | US20060179497 Methods to treat conditions associated with insulin signaling dysregulation |
| 08/10/2006 | US20060179496 Nucleic acid sequences differentially expressed in cancer tissue |
| 08/10/2006 | US20060178337 Method for diagnosing aplasia of corpus callosum |
| 08/10/2006 | US20060178336 Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
| 08/10/2006 | US20060178335 Methods and means for obtaining modified phenotypes |
| 08/10/2006 | US20060178334 Double-stranded and single-stranded RNA molecules with 5 ' triphosphates and their use for inducing interferon |
| 08/10/2006 | US20060178333 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof |
| 08/10/2006 | US20060178332 reducing an accumulation of collagen associated with chronic kidney disease, renal fibrosis or renal sclerosis by administering to the human subject a full-length nephroblastoma overexpressed gene product or protein (CCN3) |
| 08/10/2006 | US20060178331 Antisense oligonucleotides targeting folate receptor alpha, and the use thereof |
| 08/10/2006 | US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1 |
| 08/10/2006 | US20060178329 Rna sequence for therapy of cancer; control degradation and block transscription of messenger Rna that is translation product of target gene |
| 08/10/2006 | US20060178328 Brain delivery of small interfering RNA or vectors containing the DNA encoding for small interfering RNA; beneficial effects on improving memory and/or cognitive function in a subject. |
| 08/10/2006 | US20060178327 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation and function of small interfering RNA in vivo and in vitro |
| 08/10/2006 | US20060178326 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 08/10/2006 | US20060178325 nucleosides; phosphorothioate linkages |
| 08/10/2006 | US20060178324 Lipophilic derivatives of double-stranded ribonucleic acid |
| 08/10/2006 | US20060178323 Methods for the treatment of chronic pain and compositions therefor |
| 08/10/2006 | US20060178318 Use of aurora kinase inhibitors for reducing the resistance of cancer cells |
| 08/10/2006 | US20060178306 Treating amyotrophic lateral sclerosis (ALS) by administering a transthyretin protein, 7B2 protein, a cystatin C protein, a neuroendocrine protein, a cysteine protease inhibitor, or an inhibitor of an enzyme that processes a 7B2 protein |